Holds one active US DMF and one valid CEP for levofloxacin, filing since 2003. Its 2025 FDA inspection closed as NAI, and its GMP is recognised in 26 markets.
Holds one active US DMF and 2 valid CEPs for levofloxacin, filing since 2008. Its 2024 FDA inspection closed as VAI, and its GMP is recognised in 29 markets.
Holds one active US DMF and one valid CEP for levofloxacin, filing since 2018. Its 2024 FDA inspection closed as VAI, and its GMP is recognised in 4 markets.
Holds one active US DMF and one valid CEP for levofloxacin, filing since 2005. Its 2025 FDA inspection closed as VAI, and its GMP is recognised in 25 markets.
Holds 2 active US DMFs and one valid CEP for levofloxacin, filing since 2005. Its 2025 FDA inspection closed as VAI, and its GMP is recognised in 2 markets.
Holds 2 active US DMFs for levofloxacin, filing since 2010. Its 2025 FDA inspection closed as VAI, and its GMP is recognised in 6 markets.
Holds 2 active US DMFs for levofloxacin, filing since 2002. Its 2025 FDA inspection closed as VAI, and its GMP is recognised in 34 markets.
Holds one active US DMF and one valid CEP for levofloxacin, filing since 2008. Its 2025 FDA inspection closed as VAI.
Holds one active US DMF for levofloxacin, filing since 2010.
The names are listed below. The filings, inspection history and GMP certificates behind each one are available with a free account.
Open the full list with a free accountThis page filters the worldwide Levofloxacin manufacturer list to companies based in India. The order is set by active filings weighted by regulator, inspection outcomes and their recency, breadth of GMP recognition, and evidence of real exports, less any open risk flags. Read the full method.
Tell us which markets you need to file in. These suppliers come back tiered for those markets, with the price corridor and an RFI sheet.
Start for free